• In early February 2026, Equifax reported fourth-quarter 2025 results showing higher sales and earnings than a year earlier, issued full-year 2026 revenue guidance of US$6.66–US$6.78 billion, and confirmed substantial share repurchases under its US$3 billion buyback program.
• Management highlighted growing contributions from cloud- and AI-enabled products, including new fraud and income-verification tools, as central to its 2026 growth and margin ambitions despite an expected small decline in the U.S. mortgage market.
• We’ll now look at how Equifax’s AI- and cloud-driven product expansion shapes the company’s investment narrative after its recent earnings update.

AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

What Is Equifax's Investment Narrative?

To own Equifax here, you need to be comfortable with a premium-priced data and analytics business that is leaning hard into cloud and AI to deepen its role in credit, fraud and employment verification. The latest quarter backed that narrative with higher year-on-year sales and earnings, while the 2026 revenue outlook and ongoing US$3 billion buyback frame the key short term catalysts around execution, not reinvention. New launches like Credit Abuse Risk and Income Confirm, plus the Gen Digital partnership, show how Equifax is trying to monetise its cloud migration through more specialized, AI-enabled products. Against that, the stock’s recent underperformance, high debt load and regulatory scrutiny, including changing CFPB complaint rules, keep valuation, balance sheet risk and policy shifts firmly in focus. Overall, the earnings update supports the existing thesis rather than transforming it.

However, rising product complexity and tighter rules could pressure margins in ways investors should understand. Despite retreating, Equifax's shares might still be trading above their fair value and there could be some more downside. Discover how much.

Exploring Other Perspectives

Five Simply Wall St Community fair value estimates span roughly US$257 to US$448 per share, underscoring how far apart individual views can be. Set against Equifax’s premium earnings multiple and regulatory overhang, this spread invites you to weigh both upside potential and the risks to execution and margins before forming your own view.

Explore 5 other fair value estimates on Equifax - why the stock might be worth over 2x more than the current price!

Build Your Own Equifax Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Equifax research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Equifax research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Equifax's overall financial health at a glance.

Ready For A Different Approach?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.
• Find 52 companies with promising cash flow potential yet trading below their fair value.
• Capitalize on the AI infrastructure supercycle with our selection of the 33 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.